SEMA3G: A Potential Drug Target and Biomarker (G56920)

Target Name: SEMA3G

NCBI ID: G56920

SEMA3G: A Potential Drug Target and Biomarker

SEMA3G, short for small heat- shock protein-3 gene, is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The SEMA3G gene is located on chromosome 16 and encodes a protein that is expressed in various tissues and cells of the body, including the brain, heart, liver, and pancreas.

The SEMA3G gene was first identified in the late 1990s as a gene that was expressed in the brains of individuals with Alzheimer's disease, a neurodegenerative disorder that is characterized by the progressive loss of brain cells and progressive cognitive decline. Researchers have since found that individuals with Alzheimer's disease have lower levels of SEMA3G protein in their brains compared to healthy individuals.

In addition to its potential role in Alzheimer's disease, SEMA3G has also been shown to be involved in a number of other biological processes that are relevant to human health. For example, studies have found that SEMA3G is involved in the regulation of cell death, and that it plays a role in the development and progression of cancer.

SEMA3G has also been shown to be involved in the development of neurodegenerative diseases, including Parkinson's disease and Huntington's disease. In fact, studies have found that individuals with Parkinson's disease have lower levels of SEMA3G protein in their brains compared to healthy individuals, and that individuals with Huntington's disease have higher levels of SEMA3G protein in their brains compared to healthy individuals.

In addition to its potential role in neurodegenerative diseases, SEMA3G has also been shown to be involved in the development and progression of autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis. In fact, studies have found that individuals with rheumatoid arthritis have lower levels of SEMA3G protein in their brains compared to healthy individuals, and that individuals with multiple sclerosis have higher levels of SEMA3G protein in their brains compared to healthy individuals.

SEMA3G has also been shown to be involved in a number of other biological processes that are relevant to human health, including the regulation of cell growth, cell division, and cell signaling. In addition, SEMA3G has been shown to play a role in the development and progression of a number of diseases that are characterized by the disruption of normal cellular processes, including cancer, neurofibromatosis, and neurodegenerative diseases.

Overall, SEMA3G is a gene that has been identified as a potential drug target and biomarker for a wide range of diseases. Further research is needed to fully understand the role of SEMA3G in human health and to develop effective treatments for these diseases.

Protein Name: Semaphorin 3G

Functions: Has chemorepulsive activities for sympathetic axons. Ligand of NRP2 (By similarity)

More Common Targets